Zacks Investment Research on MSN
Tempus AI stock gains following the ALERT trial result announcement
Tempus AI, Inc. TEM recently presented results from the ALERT (addressing undertreatment and health equity in aortic stenosis and mitral regurgitation using an integrated ehr platform) trial at the ...
AI healthcare data platform at 5.4x EV/sales, 49% CAGR, rising margins and catalysts. Click here to read my latest analysis.
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry ...
We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands ...
Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14, 2024, and it ...
A significant technology, Transmission electron microscopy (TEM) has found its way into cell biology since 1940. When compared with light microscopes, TEM can achieve a very high resolution due to the ...
We recently published a list of 10 Firms Post Double-Digit Gains on Thursday. In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against other firms that posted ...
View Tempus AI, Inc. Class A TEM stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results